Harrow (HROW) Accumulated Expenses (2010 - 2026)
Harrow's (HROW) quarterly Accumulated Expenses came in at $9.2 million in Q1 2026, up 371.45% year-on-year from $2.0 million in Q1 2025, and down 11.51% quarter-over-quarter from $10.4 million in Q4 2025.
Harrow (HROW) Accumulated Expenses (2010 - 2026) Analysis & Trends
Harrow's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 371.45% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 371.45% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 9.86% from the prior year.
- Accumulated Expenses fell to $9.2 million in Q1 2026 per HROW's latest filing, from $10.4 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $10.4 million in Q4 2025 and bottomed at $1.1 million in Q3 2025.
- The 5-year median for Accumulated Expenses is $5.0 million (2024), against an average of $5.1 million.
- Across the five-year window, Accumulated Expenses tumbled 85.21% in 2025 and surged 371.45% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $4.0 million in 2022, then surged by 35.4% to $5.4 million in 2023, then jumped by 74.24% to $9.5 million in 2024, then grew by 9.86% to $10.4 million in 2025, then dropped by 11.51% to $9.2 million in 2026.
- Per Business Quant, the three latest HROW Accumulated Expenses figures stand at $9.2 million (Q1 2026), $10.4 million (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 10.43 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 9.50 Mn |
| Sep 30, 2024 | 7.19 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 5.45 Mn |
| Sep 30, 2023 | 5.32 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 3.44 Mn |
| Jun 30, 2022 | 3.01 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | 2.74 Mn |
| Jun 30, 2021 | 2.39 Mn |